FOLH1 and cancer: Donato et al. [15] demonstrated an additional detection yield favoring PSMA-PET/CT over MRI for both index (14% vs. 4%) and total (18% vs. 5%) lesions, particularly showing incremental values in detecting secondary cancer foci and smaller cancers.